^Rasool, Suhail; Patel, Pooja; Johansson, Jenny; Voloboueva, Ludmila; Lee, Sangmi; Sun, Jessica; Lan, Xi; Ahmed, Taufeeq; Sun, Dongxu (December 2022). "Potential Reversal of Alzheimer's Disease pathology by Antibody TB006 Targeting Galectin‐3, the Root Cause of Oligomerization of Amyloid Proteins". Alzheimer's & Dementia. 18 (S10).
doi:
10.1002/alz.060393.
^Chaurasiya, Akash; Katke, Sumeet; Panchal, Kanan; Nirmal, Jayabalan (2023). "Biologics for the management of dementia". Nanomedicine-Based Approaches for the Treatment of Dementia: 193–234.
doi:
10.1016/B978-0-12-824331-2.00001-7.
^Rasool, Suhail; Patel, Pooja; Johansson, Jenny; Voloboueva, Ludmila; Lee, Sangmi; Sun, Jessica; Lan, Xi; Ahmed, Taufeeq; Sun, Dongxu (December 2022). "Potential Reversal of Alzheimer's Disease pathology by Antibody TB006 Targeting Galectin‐3, the Root Cause of Oligomerization of Amyloid Proteins". Alzheimer's & Dementia. 18 (S10).
doi:
10.1002/alz.060393.
^Chaurasiya, Akash; Katke, Sumeet; Panchal, Kanan; Nirmal, Jayabalan (2023). "Biologics for the management of dementia". Nanomedicine-Based Approaches for the Treatment of Dementia: 193–234.
doi:
10.1016/B978-0-12-824331-2.00001-7.